Focus on pathogens, nutrition, healthy aging, AI for lifesciences and novel therapies
Participants from academia, clinics, pharma, biotech, medtech, digital health, and IT companies (research, business development, in-licensing), corporate funds and venture capitalists are invited to participate in a brokerage event that will be run in conjunction with this conference and jointly organised by the Kanton of Zurich, Life Science Zurich & EEN Switzerland via Innosuisse.
Schlagwörter: Health B2B, healthy aging, Life Science Zurich Impact, lifesciences and novel therapies, Nutrition, pathogens